Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Elizabeth M. Streicher"'
Autor:
Margaretha de Vos, Serej D. Ley, Grant Theron, Yuri F. van der Heijden, Samantha Pillay, Brigitta Derendinger, Sebastien Gagneux, Frederik Sirgel, Marianna de Kock, Elizabeth M. Streicher, Robin M. Warren
Publikováno v:
Antimicrobial Agents and Chemotherapy. 65
Eis promoter mutations can confer reduced Mycobacterium tuberculosis kanamycin susceptibility. GenoType MTBDRsl, a widely used assay evaluating this region, wrongly classified 17/410 isolates as eis promoter wild type. Six out of seventeen isolates h
Autor:
Rebecca E. Colman, Grant Theron, Elizabeth M. Streicher, John Z. Metcalfe, Christopher J. Allender, Robin M. Warren, Darrin Lemmer, Renee A. Penaloza, David M. Engelthaler
Publikováno v:
Antimicrobial agents and chemotherapy, vol 61, iss 11
Multidrug-resistant tuberculosis (TB) presents a major public health dilemma. Heteroresistance, the coexistence of drug-resistant and drug-susceptible strains or of multiple drug-resistant strains with discrete haplotypes, may affect accurate diagnos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b359fd0b7e63e7ffda3a23a568a21ed
https://europepmc.org/articles/PMC5655066/
https://europepmc.org/articles/PMC5655066/
Autor:
Robin M. Warren, G. D. van der Spuy, McEvoy Cr, Hanekom M, T. C. Victor, Ndabambi S, P. D. van Helden, Elizabeth M. Streicher, Nulda Beyers, Martin Kidd
Publikováno v:
Journal of Clinical Microbiology. 45:1483-1490
This study aimed to reconstruct the evolutionary history of Beijing strains of Mycobacterium tuberculosis and to test the hypothesis that evolution has influenced the ability of the Beijing strains within the different Beijing sublineages to spread a
Autor:
M Bosman, Andreas H. Diacon, Mendel Carl M, Juli Ann Hepple, Alexander Pym, Robin M. Warren, Kashmeel Maharaj, Elizabeth M. Streicher, Paul D. van Helden, Talita York, Carel J. van Heerden, Marinus Barnard
Publikováno v:
Journal of Clinical Microbiology. 52:4056-4057
We developed a pyrazinamidase gene DNA-sequencing method to rapidly identify pyrazinamide resistance-causing mutations in GenoLyse-treated, smear-positive sputum specimens. The sensitivity and specificity were 90.9 and 100%, respectively, compared to